首页> 美国卫生研究院文献>PLoS Clinical Trials >Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany

【2h】

Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany

机译：估计结直肠癌的治疗费用：一种务实的方法，以德国的健康保险数据为例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe cost of colorectal cancer (CRC) treatment is a crucial parameter to inform cost-effectiveness analyses on CRC screening but it is not readily available and therefore often lacking. We aimed to elaborate and exemplify a pragmatic approach to estimate CRC treatment cost based on health insurance data from Germany.

机译：背景结直肠癌（CRC）治疗的费用是决定CRC筛查成本效益分析的关键参数，但它不易获得，因此经常缺乏。我们旨在详细阐述和举例说明一种实用的方法，根据德国的健康保险数据估算CRC治疗的费用。

著录项

期刊名称 PLoS Clinical Trials
作者
Ulrike Haug; Susanne Engel; Frank Verheyen; Roland Linder;
展开▼
作者单位

展开▼
年(卷),期 2010(9),2
年度 2010
页码 e88407
总页数 5
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance [J] . Butzke Bettina, Oduncu Fuat S., Severin Franziska, Acta oncologica. . 2016,第1a6期

机译：从德国法定健康保险的角度，Irinotecan治疗结直肠癌治疗前UGT1A1基因分型的成本效益
2. Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data [J] . Johannes Clouth, Astra M. Liepa, Guido Moeser, Health Economics Review . 2018,第1期

机译：肝细胞癌肝癌治疗后：德国法定医疗保险索赔数据的发病率，医疗利用率和成本
3. Incidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data [J] . Veronika Egen-Lappe, Ingrid K?ster, Ingrid Schubert International Journal of General Medicine . 2013,第4期

机译：脑卒中后痉挛的发病率估计和指南治疗：基于德国法定健康保险数据的分析
4. Availability and Usability of the Hospital-based Cancer Registry Data for Measuring the Quality Outcome Indicators of Healthcare Provided to Breast and Colorectal Cancer Patients at King Hussein Cancer Center [C] . Amid Abu Hmaidan, Elsie Boutou, Khaled Jamal, International Conference on Cancer Care Informatics . 2018

机译：基于医院的癌症登记系统数据的可用性和可用性，用于测量侯赛因国王癌症中心提供给乳腺癌和结直肠癌患者的医疗保健质量结果指标
5. THREE HEALTH ECONOMIC CONSEQUENCES OF CHRONIC ILLNESS: INSURANCE-RELATED JOB LOCK, INADEQUATE INSURANCE COVERAGE, AND HEALTH CARE PROVIDER'S TREATMENT COSTS. [D] . STROUPE, KEVIN TODD. 1998

机译：慢性病的三种健康经济后果：与保险有关的工作锁定，不足的保险覆盖率以及保健提供者的治疗费用。
6. Hepatocellular carcinoma after prior sorafenib treatment: incidence healthcare utilisation and costs from German statutory health insurance claims data [O] . Johannes Clouth, Astra M. Liepa, Guido Moeser, 2018

机译：索拉非尼先前治疗后的肝细胞癌：发生率医疗保健利用率和德国法定健康保险索赔数据中的费用
7. Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany. [O] . Ulrike Haug, Susanne Engel, Frank Verheyen, 2014

机译：估计结直肠癌治疗费用：一种实用的方法，例如德国的健康保险数据。
8. Health Care Systems for Tracking Colorectal Cancer Screening Tests: Final Report on the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer (SATIS-PH/CRC) Intervention [R] . Harris, D. M., Borksy, A. E. 2010

机译：用于跟踪结肠直肠癌筛查测试的医疗保健系统：跟踪和增加结直肠癌公共卫生改善筛查系统方法的最终报告（saTIs-pH / CRC）干预

Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany

摘要

著录项

相似文献

相关主题

期刊订阅